A review of 2023 and an outlook for 2024 and beyond, covering transactions in North America, Europe, Asia, and Latin America.

IFRS 17 represents a major change in financial reporting for the European insurance industry....

In 2022, life and health insurance transaction activity was down sharply. Our research points to the likely causes and projects the landscape for future mergers and acquisitions.

Success in mergers and acquisitions (M&A) often requires the potential acquirer to identify opportunities to increase the value of the target.

We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.

This paper provides an introduction to Solvency II based valuation metrics and capital generation and return metrics.

Bermuda looks particularly attractive for life insurers as a choice of domicile, given the country’s favorable treatment of capital and taxation.

A significant benefit of a cyber risk assessment during M&A due diligence is that it presents the broadest view of how to value the cyber risk of a target company, while at the same time taking into account that company's current insurance protections.

In this article, we illustrate the sorts of analyses which are possible by looking at a sample of 24 transactions in Europe over the last couple of years across a wide range of EU markets.